Company Filing History:

9 out of 613

Sankyo Company, Limited

patents

6 out of 900

Hitachi Medical Corporation

Years Active: 1976-1997

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5658942 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1997-08-19),

2. 5403860 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1995-04-04),

3. 5272174 - Hydroxy-ML-236B derivatives, their preparation and use (1993-12-21),

4. 5153124 - Hydroxyl-ML-236B derivatives, their preparation and use (1992-10-06),

5. 4997848 - Octahydronaphthalene oxime derivatives for cholesterol synthesis (1991-03-05),

6. 4683433 - Imaging method and apparatus using nuclear magnetic resonance (1987-07-28),

7. 4672320 - Imaging apparatus and method using nuclear magnetic resonance (1987-06-09),

8. 4643028 - Phasing circuit for use in a scanning type ultrasonic equipment (1987-02-17),

9. 4625171 - Imaging apparatus using nuclear magnetic resonance (1986-11-25),

10. 4604472 - Octahydronaphthalene derivatives and their preparation (1986-08-05),

11. 4357690 - Switch circuit for exciting ultrasonic transducer elements (1982-11-02),

12. 4323648 - Preparation of Monacolin K (1982-04-06),

13. 4254662 - Multiple acoustic beamformer step scanner (1981-03-10),

14. 4215584 - Method for transmission and reception of ultrasonic beams using (1980-08-05),

15. 4099419 - Ultrasonic tomography apparatus (1978-07-11),

Title: The Innovative Contributions of Masao Kuroda

Introduction

Masao Kuroda is a prominent inventor based in Hiromachi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds that inhibit cholesterol synthesis. With a total of 18 patents to his name, Kuroda's work has implications for treating cholesterol-related disorders in both humans and animals.

Latest Patents

Kuroda's latest patents focus on octahydronaphthalene oxime compounds that serve as inhibitors for cholesterol synthesis. These compounds are characterized by a specific formula where R can represent hydrogen, methyl, or hydroxy, while X can be an alkyl, alkenyl, cycloalkyl, aryl, or aralkyl group. The compounds exhibit valuable antihypercholesteremic activities, making them potential candidates for treating disorders arising from blood cholesterol imbalances.

Career Highlights

Throughout his career, Kuroda has worked with notable companies such as Sankyo Company, Limited and Hitachi Medical Corporation. His experience in these organizations has allowed him to refine his expertise in the field of pharmaceutical chemistry and contribute to innovative solutions for health-related issues.

Collaborations

Kuroda has collaborated with esteemed colleagues, including Yoshio Tsujita and Toshio Kondo. These partnerships have further enhanced his research and development efforts, leading to advancements in the understanding and treatment of cholesterol-related conditions.

Conclusion

Masao Kuroda's innovative work in developing octahydronaphthalene oxime compounds highlights his significant contributions to medical chemistry. His patents and collaborations reflect a commitment to addressing critical health challenges related to cholesterol.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.